Press Releases

T-Cell Lymphoma Market is Forecasted to Hit US$ 6.5 Bn By 2031 | CAGR 15.2%

T-Cell Lymphoma Market Expected to Achieve US$ 6.5 Bn by 2030 with CAGR 15.2%.

  • Date: 29 Mar, 2024
  • Author: Sagar Karlekar
Paranasal Sinus Cancer Market is Forecasted to Hit US$ 585 Mn By 2031 | CAGR 5.2%

Global Paranasal Sinus Cancer Market is expected to reach US$ 585 Mn in 2031 with a growth rate of 5.2%.

  • Date: 29 Mar, 2024
  • Author: Sagar Karlekar
Post Cardiac Arrest Syndrome Market is Forecasted to Hit US$ 3.0 Bn By 2031 | CAGR 6.7%

Global Post Cardiac Arrest Syndrome Market is expected to reach US$ 3.0 Bn by 2031, expanding at a CAGR of 6.7% during the forecast period.

  • Date: 29 Mar, 2024
  • Author: Sagar Karlekar
Chagas Disease Market Expected to Reach US$ 496.5 Mn by 2031 | CAGR of 6.5%

The Global Chagas Disease Market size is anticipated to reach USD 496.5 million by 2031, expanding at a CAGR of 6.5% over the forecast period. Chagas

  • Date: 28 Mar, 2024
  • Author: Sagar Karlekar
Diabetic Foot Ulcer Treatment Market is Forecasted to Hit US$ 7.4 Bn By 2031 | CAGR 5.5%

Global Diabetic Foot Ulcer Treatment Market is expected to reach US$ 7.4 Bn in 2031 with a growth rate of 5.5%. The diabetic foot ulcer treatment mark

  • Date: 28 Mar, 2024
  • Author: Sagar Karlekar
Onychomycosis Market is Forecasted to Hit US$ 6.9 Bn By 2031 | CAGR 5.2%

Global Onychomycosis Market is expected to reach US$ 6.9 Bn in 2031 with a growth rate of 5.2%. Onychomycosis, commonly known as nail fungus, is a hig

  • Date: 28 Mar, 2024
  • Author: Sagar Karlekar
Bacterial Pneumonia Market Expected to Reach US$ 3.7 Billion by 2031 | CAGR 3.5%

The Global Bacterial Pneumonia Market is anticipated to reach US$ 3.7 billion by 2031, expanding at a CAGR of 3.5% during the forecast period from 202

  • Date: 27 Mar, 2024
  • Author: Sagar Karlekar
Friedreich’s Ataxia Market Expected to Achieve US $1.9 Bn by 2031 | CAGR 5.8%

Global Friedreich’s Ataxia Market is expected to reach US$ 1.9 Bn in 2031 with a growth rate of 5.8%. Friedreich's ataxia is a rare, inherit

  • Date: 27 Mar, 2024
  • Author: Sagar Karlekar
Vasculitis Market is Forecasted to Hit US$ 7.3 Bn By 2031 | CAGR 6.3%

The Global Vasculitis Market size is anticipated to reach USD 7.3 billion by 2031, expanding at a CAGR of 6.3% over the forecast period of 2024 to 203

  • Date: 27 Mar, 2024
  • Author: Sagar Karlekar
Testicular Cancer Market is Forecasted to Hit US$ 1,083.3 Mn By 2031 | CAGR 5.8%

Global Testicular Cancer Market is expected to reach US$ 1,083.3 million in 2031 with a growth rate of 5.8%. The testicular cancer drugs market consis

  • Date: 27 Mar, 2024
  • Author: Sagar Karlekar
Seasonal Influenza Market is Forecasted to Hit US$ 10.0 Bn By 2031 | CAGR 5.5%

Global Seasonal Influenza Market is expected to reach US$ 10.0 Bn in 2031 with a growth rate of 5.5%.

  • Date: 26 Mar, 2024
  • Author: Sagar Karlekar
Postoperative Pain Market is Forecasted to Hit US$ 32.3 Bn By 2031 | CAGR 7.2%

Global Postoperative Pain Market is expected to reach US$ 32.3 Bn in 2031 with a growth rate of 7.2%. Postoperative pain management is a key component

  • Date: 26 Mar, 2024
  • Author: Sagar Karlekar
Multiple Myeloma Market is Forecasted to Hit US$ 26.1 Bn By 2031 | CAGR 5.8%

Global Multiple Myeloma Market is expected to reach US$ 26.1 Bn in 2031 with a growth rate of 5.8%. Multiple myeloma is a type of blood cancer origina

  • Date: 26 Mar, 2024
  • Author: Sagar Karlekar
Hemophilia Market is Forecasted to Hit US$ 17.2 Bn By 2031 | CAGR 4.5%

The Global Hemophilia Market is poised to reach a valuation of US$ 17.2 billion by 2031, expanding at a CAGR of 4.5% during the forecast period 2024-2

  • Date: 25 Mar, 2024
  • Author: Sagar Karlekar
Natural Killer Cells Market Expected to Achieve US$ 6.0 Billion by 2031 | CAGR 34.5%

Global Natural Killer Cells Market is expected to reach US$ 6.0 Bn in 2031 with a growth rate of 34.5%. Natural killer (NK) cells are emerging as an i

  • Date: 25 Mar, 2024
  • Author: Sagar Karlekar